MedPath

EMOBOT

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Validation of EmoDTx as a Digital Endpoint for Mood Monitoring in Adult Patients Suffering From Unipolar Depression

Not yet recruiting
Conditions
Unipolar Depression
Major Depressive Disorder (MDD)
Depression
First Posted Date
2025-03-05
Last Posted Date
2025-03-05
Lead Sponsor
Emobot
Target Recruit Count
98
Registration Number
NCT06860165

Evaluation of the Concordance Between Measures Obtained by a Medical Device for Emotional Monitoring (EMOCARE) and the Patient Health Questionnaire (PHQ-9) Score in Patients With Mild to Moderate Depressive Episode

Not Applicable
Recruiting
Conditions
Major Depressive Disorder (MDD)
First Posted Date
2024-09-19
Last Posted Date
2025-07-03
Lead Sponsor
Emobot
Target Recruit Count
104
Registration Number
NCT06601140
Locations
🇫🇷

Centre Psychothérapique de Nancy, Laxou, France

🇫🇷

Private psychiatric practice, Saint Nazaire, France

🇫🇷

Centre Hospitalier Universitaire de Nantes, Nantes, France

and more 1 locations

Acquisition and Analysis of Relationships Between Longitudinal Emotional Signals Produced by an Artificial Intelligence Algorithm and Self-questionnaires Used in the Psychiatric Follow-up of Patients With Mood and/or Anxiety Disorders: a Real-Environment Study.

Not yet recruiting
Conditions
Anxiety Disorders
Major Depressive Disorder
First Posted Date
2023-08-14
Last Posted Date
2023-08-15
Lead Sponsor
Emobot
Target Recruit Count
50
Registration Number
NCT05988840

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.